← Open Payments lookup

CLAUDIA GORE: Open Payments

NPI 1700429164 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,863 in 102 payments from 15 companies in 2025. Trend: 2023 $2,380 · 2024 $2,175 · 2025 $1,863

Food & beverage: $1,752Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$281
Neurocrine BioSciences, Inc.9$236
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$215
ABBVIE INC.27$211
Teva Pharmaceuticals USA, Inc.8$210
Vanda Pharmaceuticals Inc.7$138
Corium, LLC5$117
Lundbeck LLC5$112
Takeda Pharmaceuticals U.S.A., Inc.5$96
Janssen Pharmaceuticals, Inc4$82

Products named: REXULTI, INGREZZA, CAPLYTA, VRAYLAR, FANAPT, Azstarys, UZEDY, TRINTELLIX.

Industry payments across AL — which companies pay providers there.